Literature DB >> 27504941

Prognostic value of 18F-FDG PET/CT for identifying high- and low-risk endometrial cancer patients.

Emre Özgü1, Murat Öz, Yunus Yıldız, Burçin Salman Özgü, Salim Erkaya, Tayfun Güngör.   

Abstract

OBJECTIVES: To assess the usefulness of adding PET/CT as a preoperative test for determining the extent of endometrial cancer and discriminating low- and high-risk patients to identify candidates for surgical staging.
MATERIAL AND METHODS: We retrospectively reviewed 86 patients with pathologically proven endometrial cancer who had undergone preoperative ¹⁸F-FDG PET/CT. The prognostic relationships between PET/CT parameters and pathology reports were assessed.
RESULTS: The SUVmax was significantly higher in patients with FIGO stage IB or higher compared with those with stage IA; for stage III-IV compared with stage I-II; and for patients with lymph node metastasis compared with those without lymph node metastasis. Using 6.70 as a cut-off for SUVmax, low-risk patients can be identified with a sensitivity of 92.9%.
CONCLUSIONS: PET/CT imaging can be used not only for determining malignancy and lymph node involvement but also for determining candidates for surgical staging with high sensitivity.

Entities:  

Keywords:  PET/CT; SUVmax; endometrial cancer; prognosis

Mesh:

Substances:

Year:  2016        PMID: 27504941     DOI: 10.5603/GP.2016.0032

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  2 in total

1.  Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters.

Authors:  Haejun Lee; Kyung-Hoon Hwang; Kwang An Kwon
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

2.  Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?

Authors:  Varol Gülseren; Mustafa Kocaer; Özgü Çelikkol Güngördük; İsa Aykut Özdemir; Muzaffer Sancı; Kemal Güngördük
Journal:  Turk J Obstet Gynecol       Date:  2018-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.